HIV PEP: Stop HIV within 72 hours of sex HIV Test: 20 min result, 28 days after sex STD Testing: Full & comprehensive
Genital warts treatment, Singapore (SG) | HIV STD TESTING SINGAPORE™
Genital warts treatment, Singapore (SG) | HIV STD TESTING SINGAPORE™ @singaporegenital_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) screening/diagnosis, testing/check treatment/removal/cure, Singapore. Private and confidential service. Definitions, references, and latest news.
Genital warts: penile warts / vaginal warts / anal warts / anogenital warts / venereal warts / condyloma / condylomata acuminata / "cauliflower" sex disease.
| Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic: |
| SHIM CLINIC|
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital warts treatment, Singapore (SG)
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
(of HIV/STD/pregnancy), and what you can do before and after exposure.
Cervical Cancer Screening by HPV Testing and Cytology Triage
Mon, 01 Jun 2015 00:00:00 +0100 | JAMA Internal Medicine
To the Editor In her Viewpoint about human papillomavirus (HPV) testing for primary cervical cancer screening, Feldman discusses the possible increase in costs, in particular for colposcopies. However, in the European trials, HPV-based screening followed by cytology triage of HPV-positive women was compared with screening based on Papanicolaou testing. The biopsy rate was so similar and with such narrow confidence intervals (relative risk, 1.02; 95% CI, 0.97-1.07) that there was strong evidence of a lack of difference between the approaches. (Source: JAMA Internal Medicine)
Human papillomavirus prevalence to age 60 years among Australian women prevaccination
Mon, 01 Jun 2015 00:00:00 +0100 | Sexual Health
In this study, we describe the prevalence of HPV at the cervix among Australian women before the commencement of the HPV vaccination program. Women aged 15 to 60 years attending health services for cervical screening between 2005 and 2008 were invited to participate. Liquid based cervical specimens were tested for 37 types of HPV using linear array. Among 1929 women aged 15–60 years, HPV prevalence peaked at 64% at age 15–20 years, then declined gradually to 12% at age 41–45 years, whereafter it rose to 19% in women 51–55 years then returned to 14% in 56–60 year olds. The shape of the prevalence curve we observed is similar to those from other Western populations. Variation in prevalence curves is likely due to differences in sexual behaviour between popu...
Women's views on human papillomavirus self-sampling: focus groups to assess acceptability, invitation letters and a test kit in the Australian setting
Mon, 01 Jun 2015 00:00:00 +0100 | Sexual Health
Farhana Sultana, Robyn Mullins, Michael Murphy, Dallas R. English, Julie A. Simpson, Kelly T. Drennan, Stella Heley, C. David Wrede, Julia M. L. Brotherton, Marion Saville, Dorota M. Gertig
Public Awareness of Human Papillomavirus as a Causative Factor for Oropharyngeal Cancer
Mon, 01 Jun 2015 00:00:00 +0100 | Otolaryngology - Head and Neck Surgery
Prevalence of anal dysplasia in patients with inflammatory bowel disease
Mon, 01 Jun 2015 00:00:00 +0100 | Clinical Gastroenterology and Hepatology
We examined the prevalence of abnormal anal cytology among IBD patients, and its relation to human papilloma virus (HPV). (Source: Clinical Gastroenterology and Hepatology)
Kerinokeratosis Papulosa of Childhood
Sun, 31 May 2015 09:46:31 +0100 | Dermatology
Conclusions: Dermatoscopic examination might be a useful tool to distinguish KP from other skin lesions, e.g. common warts. The detection of HPV type 57 might hint to an etiological role of HPV for KP.Dermatology (Source: Dermatology)
Evaluation of the Natural History of cancer of the cervix, implications for prevention. The Cancer Risk Management Model (CRMM)- Human PapillomaVirus and Cervical components
Sun, 31 May 2015 00:00:00 +0100 | Journal of Cancer Policy
Publication date: Available online 29 May 2015 Source:Journal of Cancer Policy Author(s): Anthony B. Miller , Steve Gribble , Claude Nadeau , Keiko Asakawa , William M. Flanagan , Michael Wolfson , Andrew Coldman , William K. Evans , Natalie Fitzgerald , Gina Lockwood , Cathy Popadiuk The Cancer Risk Management Model (CRMM) initiative of the Canadian Partnership Against Cancer offers policy makers a tool for making decisions regarding prevention and screening for their particular landscape. The cervical cancer component of CRMM is complex because the development of cervical cancer depends on HPV infection and has to take account of the fact that individuals must come in contact with one another for HPV to spread. Two tightly coupled models were built, one for the infectious spread of HPV...
Changing Incidence of Oropharyngeal and Oral Cavity Cancers
Sun, 31 May 2015 00:00:00 +0100 | Cancer Epidemiology Biomarkers and Prevention
Conclusions: The observed increasing HPV-related cancer rates are most evident among nonsmokers, whereas the decreasing HPV-unrelated cancer rates are least evident among younger individuals, nonsmokers, and those without an alcohol abuse history.
CIN2+ Risk of Women Screened by HPV and Cytology Testing
Sun, 31 May 2015 00:00:00 +0100 | Cancer Prevention Research
In conclusion, HPV-positive women with normal cytology and a negative triage test, either repeat cytology after 12 months or baseline HPV 16/18 genotyping, develop a non-negligible CIN3+ risk over 5 years. Therefore, extension of the screening interval over 5 years only seems possible for HPV screen–negative women. Cancer Prev Res; 8(6); 502–8. ©2015 AACR. (Source: Cancer Prevention Research)
Early effects of human papillomavirus vaccination in Belgium
Sat, 30 May 2015 04:47:31 +0100 | European Journal of Cancer Prevention
This study assesses the trend of HPV 16/18 infections in women less than 25 years of age participating in opportunistic cervical cancer screening. A significant reduction in the prevalence of HPV 16 [relative risk (RR)=0.61, 95% confidence interval=0.39–0.95] and a nonsignificant reduction in HPV 18 (RR=0.65, 95% confidence interval=0.29–1.48) was found in the youngest group (15–19 years). The prevalences in the older age group did not change significantly. These findings show the early effects of HPV vaccination and confirm the effectiveness of immunization in a real-life setting. (Source: European Journal of Cancer Prevention)